Clin2
NCT07036172Possibly a fitRecruiting

Semaglutide vs Wegovy for weight loss in Chinese adults

Obesity Control

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial compares a semaglutide injection to the already-approved weight loss drug Wegovy in Chinese adults with obesity. It aims to see if the new option works just as well to help people lose weight.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
460 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • Your body mass index (BMI) is 28 or higher.
  • You have not lost or gained more than 5% of your body weight in the last 3 months.
  • You do not have type 1 or type 2 diabetes.
  • You have not had any weight-loss surgery or used a weight-loss device before.
  • You have no history of pancreatitis, certain thyroid cancers, or recent serious heart problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07150975Recruiting· Phase 3
Study comparing new weekly injection vs. Wegovy for weight loss

This trial tests a new weekly injection called GZR18 against the existing drug Wegovy for weight loss in adults who are overweight or obese. It aims to see which is more effective and safe for helping people lose weight and improve related health conditions.

Beijing
NCT06633783Not yet recruiting· Phase 3
Weekly shot for weight loss in adults with obesity

This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.

Xuancheng, Anhui
NCT07280221Enrolling by invitation
Wegovy real-world weight loss study in Korea

This study tracks how well Wegovy (a once-weekly injection for weight loss) works for people in Korea who are just starting the medication. It helps doctors understand real-world results outside of a research clinic.

Goyang-si, Gyeonggi-do
NCT07055607Enrolling by invitation
Real-world study of Wegovy for weight management

This study observes how Wegovy works in everyday medical practice for people who are starting it for the first time. It will help doctors learn more about its real-life benefits and safety.

Barcelona
NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.

NCT07779343Recruiting
Multidisciplinary support for adults living with obesity

This study tests a programme that combines medical, dietary, and behavioural support to help adults with obesity lose weight and improve their health. It looks at how well the programme works in everyday clinic settings.

Algiers

Hear when a new Obesity Control trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.